Other
Terbutaline sulfate [USAN:JAN]
Safety score · 0–100
Avoid
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
A beta-2 adrenergic bronchodilator drug used to treat asthma and COPD. Labelled with H361 (suspected reproductive toxicity) and is not permitted in cosmetic formulations under EU cosmetics law.
Terbutaline sulfate is a synthetic catecholamine that acts primarily on beta-2 receptors to relax bronchial smooth muscle. It carries the GHS signal word 'Warning' and hazard H361 (suspected reproductive toxicity). EU cosmetics regulation does not permit bronchodilator drugs as cosmetic ingredients; they are regulated as medicinal products.
Known concerns
- H361 — suspected reproductive toxicity
- EU regulated as medicinal substance, not cosmetics ingredient
- Cardiovascular effects (tachycardia, palpitations)
- Neurological effects possible
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related others
Check your shelf
Find Terbutaline sulfate [USAN:JAN] in your products.
Scan any cosmetic product with LuxSense to see if it contains Terbutaline sulfate [USAN:JAN] and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.